To Demonstrate the Relative Bioavailability of Metformin HCL 500 mg Extended Release (XR) Tablets Under Fasting Conditions

Clinical trial NCT00882882 · COMPLETED

Trial details

NCT number: NCT00882882
Sponsor: Sandoz
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type II Diabetes

Start date: 2001-06-01
Primary completion: 2001-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.